학술논문
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
Document Type
Article
Author
Hallek, M; Fischer, K; Fingerle-Rowson, G; Fink, AM; Busch, R; Mayer, J; Hensel, M; Hopfinger, G; Hess, G; von Grünhagen, U; Bergmann, M; Catalano, J; Zinzani, PL; Caligaris-Cappio, F; Seymour, JF; Berrebi, A; Jäger, U; Cazin, B; Trneny, M; Westermann, A; Wendtner, CM; Eichhorst, BF; Staib, P; Bühler, A; Winkler, D; Zenz, T; Böttcher, S; Ritgen, M; Mendila, M; Kneba, M; Döhner, H; Stilgenbauer, S
Source
In The Lancet 2010 376(9747):1164-1174
Subject
Language
ISSN
0140-6736